C&L: Horobin takes over at U3 Pharma

U3 Pharma has appointed Dr. Joanna Horobin as CEO. Dr. Horobin joins U3 Pharma from MPM Capital, where she was Entrepreneur-in-Residence.

CombiMatrix Molecular Diagnostics, a wholly-owned subsidiary of CombiMatrix, has named Dr. Matthew Moore director of research and development, Robert Embree director of laboratory operations, and John Besser CFO.

Boston Life Sciences has appointed Kenneth L. Rice, Jr., JD, LLM, MBA executive vice president of finance & administration, CFO and in-house counsel.

Adenosine Therapeutics has promoted William B. Stilley to COO, Robert D. Thompson, PhD, to vice president of chemistry, and has appointed Joel M. Linden, PhD, to the position of chairman of the board.

Etrials Worldwide has hired Pascal King, founder of Dublin-based eCRO Eclipse, to the etrials executive team as president of the company's European subsidiary.

Cephalon has hired Jeff Myers as vice president, government affairs. Most recently, he served as director of government relations at BiogenIdec.

Anika Therapeutics has appointed Kevin W. Quinlan as CFO. He joins the company from Boston Biomedica.

Dr. Stephen Grant has joined Celladon as chief medical officer. He was most recently a medical officer and team leader in the Center for Biologics Evaluation and Research, Office of Cellular, Tissue and Gene Therapy.

Interleukin Genetics has named Ramon W. Mohanlal, MD, PhD, MBA, to the post of chief medical officer. Just prior to joining Interleukin Genetics, Dr. Mohanlal spent more than three years as a medical director at Vertex Pharmaceuticals.

Spectrum Pharmaceuticals has hired Chuck Chukwumerije, PhD, as vice president, quality assurance and quality control. Prior to joining Spectrum, Chukwumerije served as executive director, supplier quality at Purdue Pharma.

Cryolife has promoted Gerald Serry as vice president of international operations.

Mark A. Kahil will join Isolagen as vice president of investor relations.

Douglas Liu joined Qiagen as vice president global operations. Liu joins Qiagen from Bayer Healthcare, where he worked as head of operations for Nucleic Acid Diagnostics in the US and in Strategic Planning and Consulting at Bayer at its German headquarters.

Adolor has named Kevin G. Taylor to the position of vice president, business development, and Randall J. Mack to the position of vice president, project management.

Eve E. Slater, MD, FACC, and Kevin Reilly have joined VaxGen's board of directors.

Ceregene has expanded its board of directors to 7 members with the election of John P. Walker as an independent board member.

SCOLR Pharma has named Hans Mueller, PhD, to its board of directors.

ViaCell has elected Dr. Paul Blake and James S. Sigler to its board of directors.

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.